The importance of identifying and treating depression in HIV infected, pregnant women: A review

Journal of Psychosomatic Obstetrics and Gynecology

Volumn 30, Issue 4, 2009, Pages 275-281

  Psaros, Christina ^a   Geller, Pamela A ^a   Aaron, Erika ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

HIV; Maternal depression; Pregnancy; Prenatal care; Provision of health services

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; SEROTONIN UPTAKE INHIBITOR;

COGNITIVE THERAPY; DEPRESSION; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR DEPRESSION; MATERNAL WELFARE; PREGNANT WOMAN; PRENATAL CARE; PSYCHOTHERAPY; REVIEW; RISK ASSESSMENT;

DEPRESSION; FEMALE; HIV; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 73349088437     PISSN: 0167482X     EISSN: 17438942     Source Type: Journal    
DOI: 10.3109/01674820903254740     Document Type: Review

References (62)

1. Minkoff H, Ahdieh L, Watts H, Greenblatt H, Schmidt J, Schneider M, Stek A. The relationship of pregnancy to the use of highly active antiretroviral therapy. Am J Obstet Gynecol 2001;184:1221-1227.
2. Whitmore S, Zhang X, Taylor A. Number of births to HIV positive women in the U.S., 2006. Conference on Retroviruses and Opportunistic Infections held at the Palais des Congres de Montreal; 2009 Feb 8-11; Montreal, Canada.
3. Ogilvie GS, Palepu A, Remple VP, Maan E, Health K, MacDonald G, Christilaw J, Berkowitz J, Fisher WA, Burdge DR. Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada. AIDS 2007. January; 21(Suppl 1): S83-S88.
4. O'Hara MW, Schlechte JA, Lewis DA, Varner MW. Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol 1991;100:63-73.
5. Folkman S. Handbook of stress: theoretical and clinical aspects. In: Psychosocial effects of HIV infection. New York: The Free Press; 1993. p 658-681.
6. Morrison MF, Petitto JM, Ten Have T, Gettes DR, Chiappini MS, Weber AL, Brinker-Spence P, Bauer RM, Douglas SD, Evans DL. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry 2002;159:789-796.
7. Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 2004;49:726-735. (Pubitemid 40100521)
8. Bledsoe SE, Grote NK. Treating depression during pregnancy and the postpartum: a preliminary meta-analysis. Res Soc Work Pract 2006;16:109-120.
9. World Health Organization. Depression [monograph online]; 2008. Available from: http://www.who.int/mental- health/management/depression/definition/en/ [Accessed 18 July 2008].
10. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity study. Arch Gen Psychiatry 1994;51:8-19.
11. Gotlib IH, Whiffen VE, Mount JH, Milne K, Cordy NI. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 1989;57:269-274.
12. Marcus SM, Flynn HA, Blow FC, Barry KL. Depressive symptoms among pregnant women screened in obstetrics settings. J Women's Health 2003;12:373-380.
13. Hobfoll SE, Ritter C, Lavin J, Hulsizer MR, Cameron RP. Depression prevalence and incidence among inner-city pregnant and postpartum women. J Consult Clin Psychol 1995;63:445-453.
14. Seguin L, Potvin L, St. Denis M, Loisell J. Depressive symptoms in the late postpartum among low socioeconomic status women. Birth 1995;26:157-163.
15. Segre LS, Losch ME, O'Hara MW. Race/ethnicity and perinatal depressed mood. J Repro Infant Psychol 2006;24: 99-106.
16. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001;158:725-730.
17. Kapetanovic S, Christensen S, Karim R, Lin F, Mack WJ, Operskalski E, Frederick T, Spencer L, Stek A, Kramer F, et al.. Correlates of perinatal depression in HIV-infected women. AIDS Patient Care STDS 2009;23:101-108.
18. Levine AB, Aaron EZ, Criniti SM. Screening for depression in pregnant women with HIV infection. J Reprod Med 2008; 53:352-356.
19. Beck CT. Predictors of postpartum depression: an update. Nurs Res 2001;50:275-285.
20. O'Hara MW, Swain AM. Rates and risk of postpartum depression: a meta-analysis. Int Rev Psychiatry 1996;8:37-54.
21. Robertson E, Grace S, Wallington T, Stewart DE. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 2004;26:289-295.
22. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med 2000;160:2101-2107.
23. Haynes RB. Compliance with therapeutic regimens. In: A critical review of the determinants of patient compliance with therapeutic regimens. Baltimore: The Johns Hopkins University Press; 1974. p 26-39.
24. Malcolm SE, Ng JJ, Rosen RK, Stone VE. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care 2003;15:251-261.
25. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-133.
26. Boarts JM, Buckley-Fischer BA, Armelie AP, Bogart LM, Delahanty DL. The impact of HIV diagnosis-related vs. nondiagnosis related trauma on PTSD, depression, medication adherence, and HIV disease markers. J Evid Based Soc Work 2009;6:4-16.
27. Jones DL, Ishii M, LaPerriere A, Stanley H, Antoni M, Ironson G, Schneiderman N, Van Splunteren F, Cassels A, Alexander K, et al.. Influencing medication adherence among women with AIDS. AIDS Care 2003;15:463-474.
28. Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, Schoenbaum EE. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002;17:377-381.
29. Low-Beer S, Yip B, O'Shaughnessy MV, Hogg RS, Montaner JS. Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr 2000;23:360-361.
30. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents [monograph online]. 2008. Available from: http://www.aidsinfo.nih.giv/ ContentFiles/ AdultandAdolescent GL.pdf [Accessed 18 June 2008].
31. Kelly JA, Otto-Salaj LL, Sikkema KJ, Pinkerton SE, Bloom FR. Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention. Health Psychol 1998;17:310-319.
32. Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, Havens P, Purswani M, Gaur AH, Chadwick EG, et al.. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis 2007; 195:1393-1395.
33. Joyce K, Diffenbacher G, Greene J, Sorokin Y. Internal and external barriers to obtaining prenatal care. Soc Work Health Care 1983;9:89-96.
34. Kelly RH, Danielson BH, Golding JM, Anders TF, Gilbert WM, Zatzick DF. Adequacy of prenatal care among women with psychiatric diagnoses giving birth in California in 1994 and 1995. Psychiatr Serv 1999;50:1584-1590.
35. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, et al..Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 1999;341:394-402. (Pubitemid 29362512)
36. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Benifla JL, Burgard M, et al.. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. J Am Med Assoc 2001;285:2083-2093.
37. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al.. Combination antiretroviral strategies for the treatment of pregnant HIV-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29:484-494. (Pubitemid 34456340)
38. Ioannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L, et al.. Perinatal transmission of human immunodeficiency virus type I by pregnant women with RNA viral loads 510 copies/ml. J Infect Dis 2001;183:539-545.
39. Perinatal HIV Guidelines Working Group. Public health service task force recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States [monograph online]. 2008. Available from: http://aidsinfo.nih. gov/ContentFiles/PerinatalGL.pdf [Accessed 16 August 2008].
40. Louis JM, Buhari MA, Blackwell SC, Refuerso J, Allen D, Gonik B, Jones TB. Characteristics associated with suboptimal viral suppression at delivery in human immunodeficiency virus-1-infected pregnant women. Am J Obstet Gynecol 2005; 193(3 part 2):1266-1269.
41. Wilson TE, Ickovics JR, Royce R, Fernandez MI, Lampe M, Koenig LJ. Prenatal care utilization and the implementation of prophylaxis to prevent perinatal HIV-1 transmission. Matern Child Health J 2004;8:13-18.
42. Smith MV, Rosenheck RA, Cavaleri MA, Howell HB, Poschman K, Yonkers KA. Screening for and detection of depression, panic disorder, and PTSD in public sector obstetric clinics. Psychiatr Serv 2004;55:407-414.
43. Mosack V, Shore ER. Screening for depression among pregnant and postpartum women. J Community Health Nurs 2006;23:37-47.
44. Murray D, Cox J. Screening for depression during pregnancy with the Edinburgh Depression Scale (EDDS). J Reprod Infant Psychol 1990;8:99-107.
45. Jesse DE, Graham M. Are you often sad and depressed? Brief measures to identify women at risk for depression in pregnancy. MCM Am J Matern Child Nurs 2005;30:40-45.
46. Jomeen J, Martin CR. Is the hospital anxiety and depression scale (HADS) a reliable screening tool in early pregnancy? Psychol Health 2004;19:787-800.
47. Karimova GK, Martin CR. A psychometric evaluation of the hospital anxiety and depression scale during pregnancy. Psychol Health Med 2003;8:89-103.
48. Flynn HA, Blow FC, Marcus SM. Rates and predictors of depression treatment among pregnant women in hospitalaffiliated obstetrics practices. Gen Hosp Psychiatry 2006;28: 289-295.
49. Harrington AR, Greene-Harrington CC. Healthy start screens for depression among urban, pregnant, postpartum, and interconceptional women. J Natl Med Assoc 2007;99:226-231.
50. Nonacs R, Cohen LS. Depression during pregnancy: diagnosis and treatment options. J Clin Psychiatry 2002;63(supplement 7):24-30.
51. Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006;113:31-35.
52. Krzystanek M, Krupka-Matuszczyk I. Bright light therapy in pregnant women depression - 3 case studies. Pyschiatr Pol 2006;40:261-267.
53. Manber R, Schnyer RN, Allen JJ, Rusch JJ, Blasey CM. Acupuncture: a promising treatment for depression during pregnancy. J Affect Disord 2004;83:89-95.
54. Patkar AA, Bilal L, Masand PS. Pharmacotherapy of depression in pregnancy. Ann Clin Psychiatry 2004;16:87-100.
55. Hendrick V, Altshuler L. Management of major depression during pregnancy. Am J Psychiatry 2002;116:2137-2138.
56. Dalessandro M, Conti CM, Gambi F, Falasca K, Doyle R Conti P, Caciagli F, Fulcheri M, Vecchiet J. Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. J Clin Psychopharmacol 2007;27:58-61.
57. Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV infected patients. J Acquir Immune Defic Syndr 2005;38:432-438.
58. Mellins CA, Chu C, Malee K, Allison S, Smith R, Harris L, et al.. Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care 2008;20: 958-968.
59. Cohn SE, Umbleja T, Mrus J, Bardeguez AD, Anderson JW, Chesney MA. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084. AIDS Patient Care STDS 2008;22:29-40.
60. Berger-Greenstein JA, Cuevas CA, Brady SA, Trezza G, Richardson MA, Keane TM. Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care STDS 2007;21:942-955.
61. Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr 2006;42:298-306.
62. Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIV positive persons: implications for effective care. Psychosom Med 2008;70:531-538.